abstract |
A combination of BCL-2/BCL-XL inhibitors and related uses. The present invention relates to the combination of Compound 1, or a pharmaceutically acceptable salt thereof, with at least one additional therapeutic agent. The present invention also relates to methods of treating or preventing disease by administering Compound 1, or a pharmaceutically acceptable salt thereof, and at least one other therapeutic agent to a subject in need thereof. |